We screened 1936 patients and enrolled 1516 , of whom 1512 were randomly assigned ( 500 to placebo , 512 to peginterferon every 2 weeks , 500 to peginterferon every 4 weeks ) ; 1332 ( 88 % ) patients completed 48 weeks of treatment .